Ayers N A, Nadeau O W, Read M W, Ray P, Carlson G M
Department of Biochemistry, College of Medicine, The University of Tennessee, Memphis, Memphis, TN 38163, USA.
Biochem J. 1998 Apr 1;331 ( Pt 1)(Pt 1):137-41. doi: 10.1042/bj3310137.
The dienophile 4-phenyl-1,2,4-triazoline-3,5-dione (PTD) was identified as a novel protein cross-linker, and utilized as a conformational probe of phosphorylase b kinase (PhK), a hexadecameric enzyme with the subunit composition (alphabetagammadelta)4. In its reaction with this enzyme, PTD produced five major cross-linked conjugates as resolved by denaturing gel electrophoresis: alphabeta, betagammagamma, alphagamma and a doublet of differently migrating homodimers, betabeta1 and betabeta2. Cross-linking in the presence of six different activators of the kinase targeted to its various subunits caused substantial changes in the amounts of three of the conjugates. The formation of alphagamma was increased by all of the activators but the largest enhancement was caused by exogenous Ca2+/calmodulin. All except one of the activators decreased the amount of betagammagamma formed, with Mg2+ having the greatest effect, and all except two increased the amount of betabeta1, with Mg2+ again having the largest influence. From the overall similarity of the changes in cross-linking by PTD induced by the various activators, we conclude that, even though they are targeted to different sites and subunits, they induce activated conformations of PhK that have certain structural features in common. Regarding the mechanism of cross-linking by PTD, its reaction with a model nucleophile suggests that its initial reaction with a side chain nucleophile of PhK involves a 1,4-conjugate addition to form a urazole adduct, with the secondary cross-linking reaction occurring through an as yet unknown pathway.
亲双烯体4-苯基-1,2,4-三唑啉-3,5-二酮(PTD)被鉴定为一种新型蛋白质交联剂,并被用作磷酸化酶b激酶(PhK)的构象探针,PhK是一种具有(αβγδ)4亚基组成的十六聚体酶。在与该酶的反应中,PTD产生了五种主要的交联共轭物,通过变性凝胶电泳分离得到:αβ、βγγ、αγ以及迁移率不同的同型二聚体ββ1和ββ2的双峰。在针对其各个亚基的六种不同激酶激活剂存在下进行交联,导致三种共轭物的量发生了显著变化。除一种激活剂外,所有激活剂都增加了αγ的形成,但最大的增强是由外源性Ca2+/钙调蛋白引起的。除一种激活剂外,所有激活剂都减少了形成的βγγ的量,其中Mg2+的影响最大,除两种激活剂外,所有激活剂都增加了ββ1的量,Mg2+的影响同样最大。从各种激活剂诱导的PTD交联变化的总体相似性来看,我们得出结论,即使它们靶向不同的位点和亚基,它们也会诱导具有某些共同结构特征的PhK激活构象。关于PTD的交联机制,其与模型亲核试剂的反应表明其与PhK侧链亲核试剂的初始反应涉及1,4-共轭加成以形成尿唑加合物,二次交联反应通过尚未知的途径发生。